Ayala Pharmaceuticals OverviewLatest profit margin for Ayala Pharmaceuticals: -5493.21% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ FollowAs of Dec 2022
Trailing 12 months ending Dec 2022
As of the most recent data (December 2022), AYLA shows a profit margin of -5493.21%. That is below the Healthcare sector average of 15.58%. Scroll down for historical charts and peer comparison views.
The Healthcare sector average profit margin is about 15.58%. Ayala Pharmaceuticals is at -5493.21%, which is lower that average. That is roughly 35349.0% below the sector mean. Use the comparison chart on this page to see how AYLA stacks up against individual peers as well.
Check the historical chart to see whether AYLA's profit margin is trending up or down. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Ayala Pharmaceuticals with peers to see if the move is company-specific or sector-wide.
Besides this profit margin page, Stockcircle has Ayala Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently -5493.21%) with ownership activity and broader fundamentals.
The Healthcare average profit margin is about 15.58%, while AYLA is at -5493.21%. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.
